If you are on the lookout for some big returns in 2025, then it could pay to listen to what analysts are saying about the ASX 200 shares in this article.
That's because they have been named as buys and tipped to rise at least 20% from current levels. Here's what you need to know about them:
This wine giant's shares came under pressure last week following the release of its half year results.
Although its result itself was relatively strong, its guidance for the full year disappointed the market.
The team at Morgans believes this is a buying opportunity for investors. In response to its results, the broker has reaffirmed its add rating on the ASX 200 share with a reduced price target of $13.43.
Based on its current share price of $10.83, this implies potential upside of 24% for investors over the next 12 months. In addition, the broker is forecasting a 3.7% dividend yield in FY 2025, which boosts the total potential return to almost 28%.
If you have a high tolerance for risk and looking for exposure to the uranium industry, then Morgans thinks that Deep Yellow could be the way to do it.
Its analysts recently visited Deep Yellow's Tumas project in Namibia ahead of its Final Investment Decision next month. It appears confident that a positive decision will be made and is recommending the uranium developer as a buy.
The note reveals that Morgans has put a speculative buy rating and $1.73 price target on the ASX 200 share. Based on its current share price of $1.25, this suggests that upside of almost 40% between now and this time next year.
Finally, Goldman Sachs thinks that CSL could be an ASX 200 share with major upside potential.
While the biotechnology giant's half year results disappointed the market, the team at Goldman Sachs saw enough to remain bullish. Particularly given the strength of the key CSL Behring business.
As a result, the broker appears to see last week's share price weakness as a buying opportunity for investors.
In response to the result, the broker has reaffirmed its buy rating with a trimmed price target of $318.40. Based on the latest CSL share price of $256.90, this implies potential upside of 24% for investors over the next 12 months.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.